The choices you make today can impact Anna’s future
Anna today: 50 years old
- Full-time teacher and mother of 2 teenagers
- Living with T2D and CKD for 6 years
Kidney profile
- Albuminuria: 50 mg/g
(+12 mg/g in the past year) - eGFR: 59 mL/min/1.73 m2
(-5 mL/min/1.73 m2 in the past year)
CV profile
- Family history of CV disease
Current medications:
- Statins
- Maximum tolerated dose of an ACEi
- T2D medications* (HbA1c: 7.7%)
Anna in the future
- Working only part time
- Less active family life due to health concerns
- Increased doses for both dyslipidemia and T2D medications
Kidney profile
- Albuminuria: 310 mg/g
- eGFR: 42 mL/min/1.73 m2
CV profile
- Coronary artery disease
- Symptomatic HFpEF
Patients with CKD are at increased risk for CV events
Without additional intervention, Anna’s risk will grow
Increased albuminuria is associated with greater CV and renal risk
Risk of CV mortality or end-stage renal disease in patients with T2D†
Adapted from Fox et al. 2012
Take action now to help prevent further CV and renal damage
The choices you make today can impact Brian’s future
Brian today: 50 years old
- Newly retired, but busy grandfather of 2
- Living with T2D and CKD for 10 years
- Had an NSTEMI 3 years ago
Kidney profile
- Albuminuria: 50 mg/g
(+12 mg/g in the past year) - eGFR: 59 mL/min/1.73 m2
(-5 mL/min/1.73 m2 in the past year)
Current medications:
- Statins
- Aspirin
- Beta blocker
- T2D medications* (HbA1c: 7.7%)
- Calcium channel blocker
- Diuretic
- Maximum tolerated dose of an ACEi
Brian in the future
- Retired; less active family life due to health concerns
- Increased doses for both dyslipidemia and T2D medications
Kidney profile
- Albuminuria: 360 mg/g
- eGFR: 38 mL/min/1.73 m2
CV profile
- Has symptomatic HFpEF
Patients with CKD are at increased risk for CV events
Without additional intervention, Brian’s risk will grow
Increased albuminuria is associated with greater CV and renal risk
Risk of CV mortality or end-stage renal disease in patients with T2D†
Adapted from Fox et al. 2012
Take action now to help prevent further CV and renal damage
The choices you make today can impact Maggie’s future
Maggie today: 60 years old
- Works full time as a teacher and is a grandmother with an active family life
- Living with T2D and CKD for 8 years
Kidney profile
- Albuminuria: 280 mg/g
(+65 mg/g in the past year) - eGFR: 54 mL/min/1.73 m2
(-10 mL/min/1.73 m2 in the past year)
Current medications:
- Statins
- Multiple T2D medications* (HbA1c: 7.7%)
- Calcium channel blocker
- Diuretic
- Maximum tolerated dose of an ACEi
Maggie in the future
- Working only part time
- Less active family life due to health concerns
Kidney profile
- Albuminuria: 780 mg/g
- eGFR: 40 mL/min/1.73 m2
CV risk factors
- Diagnosed with HFpEF
Medication changes:
- Increased doses for both dyslipidemia
and T2D medications
Patients with CKD are at increased risk for both renal and CV events
Without additional intervention, Maggie’s risk will grow
Increased albuminuria is associated with greater CV and renal risk
Risk of CV mortality or end-stage renal disease in patients with T2D†
Adapted from Fox et al. 2012